BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 21755312)

  • 1. Generation of cancerous neural stem cells forming glial tumor by oncogenic stimulation.
    Lee JS; Lee HJ; Moon BH; Song SH; Lee MO; Shim SH; Kim HS; Lee MC; Kwon JT; Fornace AJ; Kim SU; Cha HJ
    Stem Cell Rev Rep; 2012 Jun; 8(2):532-45. PubMed ID: 21755312
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of oxidative metabolism leads to p53 genetic inactivation and transformation in neural stem cells.
    Bartesaghi S; Graziano V; Galavotti S; Henriquez NV; Betts J; Saxena J; Minieri V; A D; Karlsson A; Martins LM; Capasso M; Nicotera P; Brandner S; De Laurenzi V; Salomoni P
    Proc Natl Acad Sci U S A; 2015 Jan; 112(4):1059-64. PubMed ID: 25583481
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SIRT1 is required for oncogenic transformation of neural stem cells and for the survival of "cancer cells with neural stemness" in a p53-dependent manner.
    Lee JS; Park JR; Kwon OS; Lee TH; Nakano I; Miyoshi H; Chun KH; Park MJ; Lee HJ; Kim SU; Cha HJ
    Neuro Oncol; 2015 Jan; 17(1):95-106. PubMed ID: 25096191
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loss of p53 cooperates with K-ras activation to induce glioma formation in a region-independent manner.
    Muñoz DM; Tung T; Agnihotri S; Singh S; Guha A; Zadeh G; Hawkins C
    Glia; 2013 Nov; 61(11):1862-72. PubMed ID: 24038521
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The neural stem cell fate determinant TLX promotes tumorigenesis and genesis of cells resembling glioma stem cells.
    Park HJ; Kim JK; Jeon HM; Oh SY; Kim SH; Nam DH; Kim H
    Mol Cells; 2010 Nov; 30(5):403-8. PubMed ID: 20814749
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distinct neural stem cell populations give rise to disparate brain tumors in response to N-MYC.
    Swartling FJ; Savov V; Persson AI; Chen J; Hackett CS; Northcott PA; Grimmer MR; Lau J; Chesler L; Perry A; Phillips JJ; Taylor MD; Weiss WA
    Cancer Cell; 2012 May; 21(5):601-613. PubMed ID: 22624711
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loss of p53 Concurrent with RAS and TERT Activation Induces Glioma Formation.
    Gong M; Fan X; Yu H; Niu W; Sun S; Wang H; Chen X
    Mol Neurobiol; 2023 Jun; 60(6):3452-3463. PubMed ID: 36867344
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Brain cancer stem-like cell genesis from p53-deficient mouse astrocytes by oncogenic Ras.
    Lee JS; Gil JE; Kim JH; Kim TK; Jin X; Oh SY; Sohn YW; Jeon HM; Park HJ; Park JW; Shin YJ; Chung YG; Lee JB; You S; Kim H
    Biochem Biophys Res Commun; 2008 Jan; 365(3):496-502. PubMed ID: 18021740
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SOX5/6/21 Prevent Oncogene-Driven Transformation of Brain Stem Cells.
    Kurtsdotter I; Topcic D; Karlén A; Singla B; Hagey DW; Bergsland M; Siesjö P; Nistér M; Carlson JW; Lefebvre V; Persson O; Holmberg J; Muhr J
    Cancer Res; 2017 Sep; 77(18):4985-4997. PubMed ID: 28687615
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mouse induced glioma-initiating cell models and therapeutic targets.
    Kondo T
    Anticancer Agents Med Chem; 2010 Jul; 10(6):471-80. PubMed ID: 20879984
    [TBL] [Abstract][Full Text] [Related]  

  • 11. p53 and NF 1 loss plays distinct but complementary roles in glioma initiation and progression.
    Gonzalez PP; Kim J; Galvao RP; Cruickshanks N; Abounader R; Zong H
    Glia; 2018 May; 66(5):999-1015. PubMed ID: 29392777
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Tumor Suppressor Function for Notch Signaling in Forebrain Tumor Subtypes.
    Giachino C; Boulay JL; Ivanek R; Alvarado A; Tostado C; Lugert S; Tchorz J; Coban M; Mariani L; Bettler B; Lathia J; Frank S; Pfister S; Kool M; Taylor V
    Cancer Cell; 2015 Dec; 28(6):730-742. PubMed ID: 26669487
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor induction by ras and myc oncogenes in fetal and neonatal brain: modulating effects of developmental stage and retroviral dose.
    Radner H; el-Shabrawi Y; Eibl RH; Brüstle O; Kenner L; Kleihues P; Wiestler OD
    Acta Neuropathol; 1993; 86(5):456-65. PubMed ID: 8310796
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A hypothesis: neural glial cells, neural stem cells and tumor stem cells transform each other depending on the micro-ecological environment].
    Huang Q; DU ZW
    Zhonghua Zhong Liu Za Zhi; 2010 Jan; 32(1):76-8. PubMed ID: 20211077
    [No Abstract]   [Full Text] [Related]  

  • 15. Stem cells in brain tumorigenesis and their impact on therapy.
    Cardona AF; Balañá C; Torres D; Becerra H; Ortíz LD; Fadul CE
    Curr Stem Cell Res Ther; 2011 Dec; 6(4):339-49. PubMed ID: 21466481
    [TBL] [Abstract][Full Text] [Related]  

  • 16. p53 and Pten control neural and glioma stem/progenitor cell renewal and differentiation.
    Zheng H; Ying H; Yan H; Kimmelman AC; Hiller DJ; Chen AJ; Perry SR; Tonon G; Chu GC; Ding Z; Stommel JM; Dunn KL; Wiedemeyer R; You MJ; Brennan C; Wang YA; Ligon KL; Wong WH; Chin L; DePinho RA
    Nature; 2008 Oct; 455(7216):1129-33. PubMed ID: 18948956
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel drug conjugate, NEO212, targeting proneural and mesenchymal subtypes of patient-derived glioma cancer stem cells.
    Jhaveri N; Agasse F; Armstrong D; Peng L; Commins D; Wang W; Rosenstein-Sisson R; Vaikari VP; Santiago SV; Santos T; Chen L; Schönthal AH; Chen TC; Hofman FM
    Cancer Lett; 2016 Feb; 371(2):240-50. PubMed ID: 26683773
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-level expression of H-ras and c-myc oncogenes in mycoplasma-mediated malignant cell transformation.
    Zhang B; Shih JW; Wear DJ; Tsai S; Lo SC
    Proc Soc Exp Biol Med; 1997 Apr; 214(4):359-66. PubMed ID: 9111527
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Qki deficiency maintains stemness of glioma stem cells in suboptimal environment by downregulating endolysosomal degradation.
    Shingu T; Ho AL; Yuan L; Zhou X; Dai C; Zheng S; Wang Q; Zhong Y; Chang Q; Horner JW; Liebelt BD; Yao Y; Hu B; Chen Y; Fuller GN; Verhaak RG; Heimberger AB; Hu J
    Nat Genet; 2017 Jan; 49(1):75-86. PubMed ID: 27841882
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transformation of quiescent adult oligodendrocyte precursor cells into malignant glioma through a multistep reactivation process.
    Galvao RP; Kasina A; McNeill RS; Harbin JE; Foreman O; Verhaak RG; Nishiyama A; Miller CR; Zong H
    Proc Natl Acad Sci U S A; 2014 Oct; 111(40):E4214-23. PubMed ID: 25246577
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.